DRIO

MKT CAP:$53M

DarioHealth Corp.

Market Cap

$53M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$7.19-$3.33 (-31.65%)

Apr 24, 2026

Company Details

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, h...

CEO

Erez Raphael

IPO Date

Mar 14, 2016

Website

www.mydario.com

Key Metrics TTM

Revenue

$25M

+7.3% YoY

Net Income

-$34M

EPS (Diluted)

$0.06

Free Cash Flow

-$27M

Revenue / Share

$0.50

Gross Margin

63.8%

Operating Margin

84.1%

Net Margin

-137.2%

FCF Margin

-108.9%

P/S

2.2x

P/E

—

Earnings Reports

Q4 2025

May 13, 2026

PENDING

FY 2025

Mar 19, 2026

$22M-17.3%EPS $1.24

Q3 2025

Nov 13, 2025

$5M-32.5%EPS $0.38

Q2 2025

Aug 12, 2025

$5M-14.2%EPS -$0.20

Q1 2025

May 14, 2025

$7M+17.3%EPS $0.14

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$6M	$2M	-$22M
Q1 22	$8M	$4M	$16M
Q2 22	$6M	$2M	$17M
Q3 22	$7M	$3M	$15M
Q4 22	$7M	$4M	$9M
Q1 23	$7M	$3M	$12M
Q2 23	$6M	$3M	$14M
Q3 23	$4M	$610.0K	$16M
Q4 23	$4M	$1M	$14M
Q1 24	$6M	$2M	$18M
Q2 24	$6M	$4M	$16M
Q3 24	$7M	$5M	$12M
Q4 24	$8M	$5M	$12M
Q1 25	$7M	$4M	$9M
Q2 25	$5M	$3M	$9M
Q3 25	$5M	$3M	-$9M

Valuation

Quarter	P/S	P/E
Q4 21	260.4x	—
Q1 22	97.1x	—
Q2 22	103.0x	—
Q3 22	90.6x	—
Q4 22	95.7x	—
Q1 23	83.1x	—
Q2 23	89.8x	—
Q3 23	78.3x	—
Q4 23	58.2x	—
Q1 24	61.9x	—
Q2 24	49.4x	—
Q3 24	39.3x	—
Q4 24	23.5x	—
Q1 25	21.7x	—
Q2 25	24.5x	—
Q3 25	31.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$15M	-$15M
Q1 22	-$18M	-$18M
Q2 22	-$11M	-$11M
Q3 22	-$11M	-$11M
Q4 22	-$8M	-$8M
Q1 23	-$5M	-$5M
Q2 23	-$10M	-$10M
Q3 23	-$9M	-$9M
Q4 23	-$7M	-$7M
Q1 24	-$13M	-$13M
Q2 24	-$11M	-$11M
Q3 24	-$7M	-$7M
Q4 24	-$7M	-$7M
Q1 25	-$7M	-$7M
Q2 25	-$6M	-$6M
Q3 25	-$7M	-$7M

Capital Expenditures

Quarter	CapEx
Q4 21	$68.0K
Q1 22	$66.0K
Q2 22	$159.0K
Q3 22	$289.0K
Q4 22	$59.0K
Q1 23	$74.0K
Q2 23	$146.0K
Q3 23	$281.0K
Q4 23	$83.0K
Q1 24	$56.0K
Q2 24	$29.0K
Q3 24	$32.0K
Q4 24	$21.0K
Q1 25	$31.0K
Q2 25	$44.0K
Q3 25	$41.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+189.8%	+148.5%
Q1 22	+124.2%	+27.2%
Q2 22	+17.5%	-148.0%
Q3 22	+17.3%	-128.3%
Q4 22	+13.0%	-107.9%
Q1 23	-12.3%	+31.6%
Q2 23	-0.5%	+29.6%
Q3 23	-46.7%	-51.0%
Q4 23	-46.9%	-381.6%
Q1 24	-18.5%	-126.4%
Q2 24	+1.7%	-26.3%
Q3 24	+111.0%	+61.7%
Q4 24	+110.3%	+61.7%
Q1 25	+17.3%	+78.0%
Q2 25	-14.2%	+61.4%
Q3 25	-32.5%	+414.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$6M	104.5%
Q1 22	$5M	66.3%
Q2 22	$0	0.0%
Q3 22	$5M	74.6%
Q4 22	$3M	45.2%
Q1 23	$5M	68.7%
Q2 23	$5M	86.0%
Q3 23	$5M	146.6%
Q4 23	$4M	121.5%
Q1 24	$7M	119.1%
Q2 24	$4M	56.9%
Q3 24	$3M	37.5%
Q4 24	$3M	34.1%
Q1 25	$2M	34.7%
Q2 25	$2M	37.9%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 21	$5M	$5M	$12M
Q1 22	$6M	$4M	$10M
Q2 22	$4M	$5M	$9M
Q3 22	$5M	$4M	$8M
Q4 22	$5M	$3M	$4M
Q1 23	$5M	$4M	$6M
Q2 23	$5M	$4M	$6M
Q3 23	$6M	$4M	$6M
Q4 23	$4M	$5M	$5M
Q1 24	$7M	$7M	$7M
Q2 24	$7M	$5M	$7M
Q3 24	$5M	$4M	$7M
Q4 24	$5M	$4M	$6M
Q1 25	$4M	$3M	$6M
Q2 25	$4M	$3M	$5M
Q3 25	$3M	$5M	$5M

Revenue Segments

Quarter	Products	Services	Commercial	Consumers
Q4 21	$5M	$848.0K	—	—
Q1 22	—	—	$5M	$4M
Q2 22	—	—	$3M	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$56M	$0	$56M
Q2 22	$68M	$0	$68M
Q3 22	$57M	$0	$57M
Q4 22	$49M	$0	$49M
Q1 23	$39M	$4M	$43M
Q2 23	$53M	$0	$53M
Q3 23	$44M	$0	$44M
Q4 23	$37M	$0	$37M
Q1 24	$34M	$0	$34M
Q2 24	$23M	$0	$23M
Q3 24	$16M	$0	$16M
Q4 24	$28M	$697.0K	$28M
Q1 25	$28M	$0	$28M
Q2 25	$22M	$0	$22M
Q3 25	$32M	$0	$32M
Q4 25	$26M	$0	$26M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	16M	-4.7%	+114.1%
Q1 22	20M	+25.1%	+39.9%
Q2 22	22M	+14.3%	+42.9%
Q3 22	23M	+2.4%	+39.5%
Q4 22	26M	+12.0%	+63.9%
Q1 23	28M	+7.2%	+40.5%
Q2 23	28M	+2.2%	+25.7%
Q3 23	29M	+2.2%	+25.4%
Q4 23	27M	-5.6%	+5.7%
Q1 24	34M	+26.7%	+24.9%
Q2 24	40M	+15.6%	+41.3%
Q3 24	40M	+1.5%	+40.3%
Q4 24	40M	0.0%	+48.6%
Q1 25	67M	+66.2%	+95.1%
Q2 25	50M	-26.1%	+24.6%
Q3 25	50M	0.0%	+22.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$30.1K	200
Q1 22	$40.3K	200
Q2 22	$30.9K	200
Q3 22	$33.0K	200
Q4 22	$28.3K	241
Q1 23	$29.3K	241
Q2 23	$25.5K	241
Q3 23	$14.6K	241
Q4 23	$13.1K	276
Q1 24	$20.9K	276
Q2 24	$22.7K	276
Q3 24	$26.9K	276
Q4 24	$38.8K	196
Q1 25	$34.4K	196
Q2 25	$27.4K	196
Q3 25	$25.5K	196

Revenue / Employee